Table 3.
Results, in terms of mean value, obtained with GD-EOB-DTPA
| Description | Score (Mean Value) |
|---|---|
| Reader 1 | GD-EOB-DTPA |
| Degree of hyperenhancement of arterial phase | 2.7 |
| Lesion-to-liver contrast during portal phase | 4 |
| Hepatobiliary phase parenchymal hyperenhancement | 2,4 for HCC; 2,9 for mCRC with previous chemotherapy; 4 for mCRC without previous chemotherapy |
| Quality of arterial phases | 2.9 |
| Reader 2 | |
| Degree of hyperenhancement of arterial phase | 2.5 |
| Lesion-to-liver contrast during portal phase | 4 |
| Hepatobiliary phase parenchymal hyperenhancement | 2,5 for HCC; 3 for mCRC with previous chemotherapy; 4 for mCRC without previous chemotherapy |
| Quality of arterial phases | 3 |
| Reader 3 | |
| Degree of hyperenhancement of arterial phase | 2.6 |
| Lesion-to-liver contrast during portal phase | 4 |
| Hepatobiliary phase parenchymal hyperenhancement | 2,4 for HCC; 3,3 for mCRC with previous chemotherapy; 4 for mCRC without previous chemotherapy |
| Quality of arterial phases | 3 |